SCHEMBL16975190

SCHEMBL16975190

CCCCOC(=O)NC(Cc1ccc(-c2cc(Cl)ccc2F)cc1)C[C@@H](N=[N+]=[N-])C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 19/20 0.47
▸ MMEL1 Q495T6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16930571 0.89 MME (0.43) MME
SCHEMBL16941428 0.80 MME (0.51) MME
SCHEMBL24428846 0.75 MME (0.50) MME
SCHEMBL16941449 0.74 MME (0.55) MME
SCHEMBL17980322 0.73 MMP2 (0.41) MME
SCHEMBL16975182 0.73 MME (0.51) MME
SCHEMBL16930471 0.73 MME (0.51) MME
SCHEMBL16975153 0.73 MME (0.51) MME
SCHEMBL20099604 0.72 MME (0.65) MME
SCHEMBL16941033 0.71 MME (0.55) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099678-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-12-07 — — EP disclosed
WO-2015116786-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-06 — — WO disclosed
Send feedback